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Abstract Pasteurella multocida heparosan synthase
PmHS2 is a dual action glycosyltransferase that catalyzes
the polymerization of heparosan polymers in a non-
processive manner. The two PmHS2 single-action trans-
ferases, obtained previously by site-directed mutagenesis,
have been immobilized on Ni(II)-nitrilotriacetic acid aga-
rose during the purification step. A detailed study of the
polymerization process in the presence of non-equal
amounts of PmHS2 single-action transferases revealed that
the glucuronyl transferase (PmHS2-GlcUA+) is the limiting
catalyst in the polymerization process. Using experimental
design, it was determined that the N-acetylglucosaminyl
transferase (PmHS2-GlcNAc+) plays an important role in
the control of heparosan chain elongation depending on the
number of heparosan chains and the UDP-sugar concentra-
tions present in the reaction mixture. Furthermore, for the
first time, the synthesis of heparosan oligosaccharides alter-
nately using PmHS2-GlcUA+ and PmHS2-GlcNAc+ is
reported. It was shown that the synthesis of heparosan
oligosaccharides by PmHS2 single-action transferases do
not require the presence of template molecules in the reac-
tion mixture.
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Introduction
Heparin (Hep) and heparan sulfate (HS) are analog mole-
cules belonging to the glycosaminoglycan (GAG) family.
Hep/HS polymers are ubiquitous in mammalian cells and
are involved in many physiological processes (Rabenstein
2002; Linhardt and Toida 2004). Heparin is a well-known
pharmaceutical compound that is used in large amounts in
surgery for its anticoagulant properties. Heparan sulfate, an
analog of heparin, is not used yet for therapeutic purposes,
but it is considered to have a large potential for medical
applications (Rabenstein 2002; Lindahl 2007). Currently,
pharmaceutically grade heparin anticoagulant products are
mainly obtained from animal tissues, and some are chemi-
cally synthesized. Neither of these systems enable the pro-
duction of a large range of well-defined Hep/HS oligomers
and polymers; therefore, alternative processes to control
Hep/HS synthesis are of interest (Laremore et al. 2009).
Heparosan is the unsulfated precursor of heparin and
heparan sulfate in mammalians. In the pathogenic bacteria
Escherichia coli K5 (Vann et al. 1981), Pasteurella
multocida type D (Pandit and Smith 1993; Rimler 1994),
and Avibacterium paragallinarum genotype II (Wu et al.
2010), heparosan is a component of the polysaccharide
capsule. Heparosan can be produced either by extracting it
from microorganisms or by using recombinant enzymes in
vitro. The use of E. coli K5 to produce heparosan in large-
scale fermentation has been reported and enabled the recov-
ery of 15 g/L of heparosan (Wang et al. 2010). Despite the
fact that this production strategy is cost-effective, neither the
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heparosan chain length nor the incorporation of modified
and analog sugar residues can be controlled.
Heparosan can also be synthesized in vitro using recom-
binant heparosan synthases. Heparosan synthases from
mammalians (EXT1 and EXT2) (Mccormick et al. 2000;
Kim et al. 2003), Drosophila (TTV, SOTV, and BOTV)
(Bellaiche et al. 1998; Izumikawa et al. 2006), E. coli K5
(KfiA and KfiC) (Griffiths et al. 1998; Hodson et al. 2000;
Sugiura et al. 2010), and P. multocida type D (PmHS1 or
PmHS2) (Sismey-Ragatz et al. 2007; Chavaroche et al.
2010) have been characterized. EXT1 is a dual action trans-
ferase, while EXT2 and Kfi (KfiA and KfiC) heparosan
synthases are mono-action transferases that catalyze only
one transferase activity; thus, both transferases are necessary
(EXT1 and EXT2 or KfiA and KfiC) for polymerization
activity (Busse and Kusche-Gullberg 2003; Sugiura et al.
2010). In contrast, PmHS heparosan synthases (PmHS1 and
PmHS2) are both dual action glycosyltransferases exhibit-
ing a glucuronyl transferase and an N-acetylglucosaminyl
transferase activity. PmHS single-action transferase
enzymes (PmHS-GlcUA+ and PmHS-GlcNAc+) were
obtained by applying site-directed mutagenesis on the
DXD motif of PmHS1 (Kane et al. 2006) or PmHS2
(Chavaroche et al. 2011). The PmHS2-GlcUA+ and
PmHS2-GlcNAc+ incubated together polymerized heparo-
san chains (Chavaroche et al. 2011).
There is a close relationship between the Hep/HS struc-
tures and their biological activity (Bishop et al. 2007).
Indeed, it was reported that heparin pentasaccharides require
the presence of iduronic acid to exhibit anticoagulant activ-
ity, while decasaccharide heparin exhibit anticoagulant ac-
tivity in the absence of iduronic acid (Chen et al. 2007).
Moreover, heparan sulfate proteoglycans are involved in
many aspects of cancer development from cell growth to
metastasis. In this pathology, the chain length of the poly-
mers influences the biological activity. High molecular
weight heparin enhances the binding of the growth factors
to their receptors and thus promotes angiogenesis, while low
molecular weight heparin has the opposite effect by inhibit-
ing their binding (Yip et al. 2006; Lazo-Langner et al. 2007).
The relation between structure and biological activity is also
true for the antiviral activity of Hep/HS, which can also be
modulated by varying the degree of epimerization, sulfation,
or/and the chain length (Chen et al. 1997; Rusnati et al.
2009). Thus, in order to synthesize heparin and heparan
sulfate with specific chain length, it is important to control
the elongation of the polymer backbone heparosan. Recently,
the controlled synthesis of heparosan-like oligosaccharides
has been reported by applying alternately the activity of the
glycosyltransferases KfiA (N-acetyl-D-glucosaminyl transfer-
ase) and PmHS2 (N-acetylglucosaminyl transferase and glu-
curonyl transferase) in the presence of UDP-sugars and a
disaccharide acceptor (GlcUA-AnMannose) (Liu et al. 2010;
Xu et al. 2011). Nevertheless, due to the dual action of
PmHS2, the synthesis had to be carefully monitored. The
controlled synthesis of glycosaminoglycan hyaluronan and
chondroitin oligosaccharides has also been reported. Immobi-
lized P. multocida hyaluronan synthase PmHAS single-action
transferases (Deangelis et al. 2003) and immobilized E. coli
chondroitin polymerase K4CP single-action polymerases
(Sugiura et al. 2008) synthesized monodisperse 20-mer hya-
luronan chains and 16-mer chondroitin chains from short
oligosaccharide templates, respectively.
Here we report the use of an immobilized-metal affinity
chromatography (IMAC) technique for the immobilization
of PmHS2 single-action transferases (PmHS2-GlcNAc+ and
PmHS2-GlcUA+). PmHS2 enzymes immobilized with Ni
(II)-nitrilotriacetic acid (Ni-NTA) agarose were character-
ized for their polymerization activity, stability, and ability
to elongate step-by-step heparosan oligosaccharides. We
observed that the polymerization process is influenced by
both transferase activities and both UDP-sugar concentra-
tions, which make the control of heparosan chain elongation
more complicated. However, we were able to show for the
first time that both PmHS2 single-action transferases can be
used in an alternate manner and in the absence of oligosac-
charide templates to synthesize heparosan oligosaccharides.
This study opens new perspectives for the synthesis of
defined length heparosan oligosaccharides.
Experimental procedure
Protein expression, purification, and immobilization
The genes pmhs2-GlcUA+ and pmhs2-GlcNAc+ were ligat-
ed into pET101 and transformed in E. coli BL21*(DE3)
(Invitrogen) (Chavaroche et al. 2011). The recombinant
proteins PmHS2-GlcUA+ and PmHS2-GlcNAc+ were
expressed with a V5-epitope and a polyhistidine tag (His-
Tag) at their C terminus.
The protein expression and the protein recovery proce-
dures were performed as previously described (Chavaroche
et al. 2010, 2011). The soluble fraction (4 mL) obtained
from 100 mL of induced E. coli culture was added to 1 mL
of Ni-NTA agarose slurry (50:50% agarose/buffer)
(Qiagen). In order to purify and desalt PmHS2 transferases
(PD-10 purified), both the immobilization step on Ni-NTA
agarose and the desalting step of the purified fraction using
PD-10 desalting column were performed. In order to immo-
bilize PmHS2-GlcUA+ and PmHS2-GlcNAc+ on Ni-NTA
agarose, the His-Tag purification was slightly modified. The
elution step (phosphate buffer, 250 mM of imidazole) was
omitted, and the subsequent desalting step (PD10 column)
was removed. Instead, the PmHS2 single-action trans-
ferases/Ni-NTA agarose mixture was washed and
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equilibrated five times with Tris–HCl (50 mM, pH 7.15), then
three times with Tris–HCl (50 mM, pH 7.15), Mn2+/Mg2+
(11:11 mM). Prior to being stored at 4°C or to be used in
polymerization assay, 0.50 to 1.75 mL of Tris–HCl (50 mM,
pH 7.15), Mn2+/Mg2+ (4 mM each) was added to the PmHS2-
GlcUA+/agarose and/or PmHS2-GlcNAc+/agarose (referred
as immobilized enzymes).
The amount of protein immobilized onto the Ni-NTA
resin was determined by a bicinchoninic acid assay (Pierce)
using bovine serum albumin as the standard. The efficiency
of the protein binding during the washing steps and the
storage was evaluated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) analysis
(Chavaroche et al. 2010).
Standard polymerization condition
The polymerization reaction with a final volume between 30
and 200 μL contained 40 mM Tris–HCl (pH 7.15), 4 mM
MnCl2, 4 mM MgCl2, UDP-GlcUA, UDP-GlcNAc, and
PD10-purified or immobilized recombinant PmHS2 single-
action transferases. Unless otherwise mentioned, the
enzymes were freshly prepared. The amount of UDP-sugar
and enzymes varied with the experiments; details are given
in the figure legends. The reactions were performed in the
dark at 30–32°C under mild shaking conditions ranging
from 2 to 24 h.
In order to compare the storage stability of purified and
immobilized enzymes, the same amount of, either, PD10-
purified or immobilized single-action transferases was
re-suspended in 3.5 mL buffer and stored at 4 °C in the
presence of Tris–HCl (50 mM, pH 7.15), Mn2+/Mg2+
(4 mM each). At several time points, aliquots of the enzymes
were incubated at 30–32°C in the presence of UDP-sugars.
The polymerization efficiency was compared by monitoring
the conversion of UDP-sugars by the coupled enzyme assay.
Experimental design
To determine the relationship between the ratio of trans-
ferases, the UDP-sugar concentrations, and the heparosan
size distribution, samples were prepared according to a
fractional factorial design of four variables with each three
levels (34 − 1). Preliminary experiments were performed to
determine the lowest PmHS2 single-action transferase and
UDP-sugar concentrations needed to observe activity. From
these results, the concentrations for each variable were
determined (Table 1). This experimental design consisted
in the preparation of 27 reaction mixtures in which different
combinations of UDP-sugars and PmHS2 single-action
transferase concentrations were added together (Supplemen-
tary information Table 1). The samples were incubated for
4 h to avoid the complete conversion of the UDP-sugars
when low UDP-sugar concentrations were present; each
reaction mixture was analyzed for UDP content (coupled
enzyme assay) and polymer chain length (high-performance
size exclusion chromatography, HPSEC).
To analyze the data, it was decided to use the so-called
response surface methodology described by Box and Draper
(1987). The analysis of the data was done by performing a
linear regression in which 15 parameters (main effects,
quadratic effects, and interaction effects) were taken into
account. The response variable (y) was modeled using the
following equation:
y ¼ b0 þ b1x1 þ b2x2 þ b3x3 þ b4x4 þ b5x12 þ b6x22
þ b7x32 þ b8x42 þ b9x1x2 þ b10x1x3 þ b11x1x4
þ b12x2x3 þ b13x2x4 þ b14x3x4
In this case, y is the heparosan molecular weight, b0 is the
intercept, b1 to b14 the regression coefficients, and x1, x2, x3,
and x4 are the variables: PmHS2-GlcNAc
+, PmHS2-
GlcUA+, UDP-GlcUA, and UDP-GlcNAc concentration,
respectively. The estimation of the regression coefficients
was done by least squares regression.
The calculation of the so-called Mallow’s Cp criterion
was used to determine the best fit for this model. The
Mallow’s Cp criterion is calculated by taking into account
the fit of the model and giving penalties for each additional
parameter used to fit a model to the data. Thus, the best
model to represent the data is obtained when the Mallow’s
Table 1 Variables used for the fractional factorial design of four variables and three levels (34 − 1)
Variables
x1 x2 x3 x4
PmHS2-GlcNAc+ PmHS2-GlcUA+ UDP-GlcUA UDP-GlcNAc
Levels Low 7 7 0.5 0.5
Medium 21 21 2.75 2.75
High 34 34 5 5
The variables x1 and x2 are the PmHS2 single-action transferase concentrations (micrograms per milliliter), and x3 and x4 are the UDP-sugar
concentrations (millimolars), respectively
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Cp is at the lowest value. The visualization of the response
is given by a contour plot (“Results” section). In practice,
the response variable can only be visualized as a function of
two independent variables. Therefore, cross sections at dif-
ferent levels of the two other variables were made. The
visualization was done using the mathematical software
package Matlab.
Step-by-step elongation of heparosan oligosaccharides
Immobilized PmHS2 single-action transferases (0.80 ±
0.05 mg/mL Ni-NTA agarose) were transferred separately
to two empty disposable PD10 columns (GE Healthcare):
PmHS2-GlcUA+ (column A) and PmHS2-GlcNAc+
(column B) (Fig. 1). Elongation of heparosan oligosaccha-
ride was performed by addition of polymerization buffer
(Tris–HCl (50 mM, pH 7.15), Mn2+/Mg2+ (4 mM each),
and UDP-sugars (3.25 up to 6.50 mM) to the columns. With
the exception of the initiation step in column A (PmHS2-
GlcUA+) to which both UDP-sugars were added, each of the
following incubation steps contained only UDP-GlcUA or
UDP-GlcNAc for column A or B, respectively. The reaction
mixtures were transferred from column A to column B in an
alternating manner to elongate heparosan oligosaccharides
to a defined polymerization degree. Each incubation step
was performed for 3 h in the dark under orbital shaking
conditions at 32 °C. At the end of each incubation step, the
reaction mixture was released from the column (e.g.,
column A) and was heat-inactivated (15 min at 65 °C) to
avoid the possible presence of any residual enzyme activity
before being loaded onto the other column (column B), vice
versa. In addition, between each incubation cycle, the
immobilized enzymes were washed with 2×1 mL of
Tris–HCl (40 mM, pH 7.15), 4 mM Mn2+, and 4 mM Mg2+.
Analysis of the polymerization activity
For the analysis of the polymerization activity, fresh immo-
bilized and PD10-purified PmHS2 single-action transferases
were used, and the same procedures as described before
have been used (Chavaroche et al. 2010).
Coupled enzyme assay Samples were quenched by immer-
sion in liquid nitrogen, and the UDP-sugars conversion was
quantified by measuring the NADH reduction into NAD+ at
340 nm in a coupled enzyme assay (Gosselin et al. 1994;
Krupa et al. 2007).
Gel electrophoresis Heparosan oligomers/polymers synthe-
sized during the enzymatic reactions were analyzed by
Novex 20% Tris borate–EDTA (TBE) polyacrylamide gel
(Invitrogen) and 2% (w/v) agarose gel electrophoresis. The
sample preparation, the gel electrophoresis parameters, and
the staining procedures were done according to Chavaroche
et al. (2011). A selected hyaluronan molecular mass marker
ranging from 27 to 495 kDa (Select-HALoLadder, Hyalose)
was used to estimate the heparosan molecular weight.
High-performance size exclusion chromatography
analysis The size distribution and the molecular weight of
the heparosan polymers were analyzed by HPSEC on an
Ultimate 3000 (Dionex, Sunnyvale, USA) using three
TosoH Bioscience TSK-gel columns in series (4000, 3000,
and 2500 Super AW, 150×6.0 mm) preceded by a TSK AW-
L guard column (35×4.6 mm; TosoH Bioscience, Japan) as
previously described (Chavaroche et al. 2011). For each
HPSEC analysis, the molecular weight and the size distri-
bution of the samples were determined by fitting to a loga-
rithmic model the elution time of the hyaluronan molecular
mass markers (30, 160, and 262 kDa, Hyalose) (Chavaroche
et al. 2010).
High-performance anion exchange chromatography
analysis The composition of the reaction mixture (UDP-
Fig. 1 Schematic representation of the procedure for the step-by-step
elongation of heparosan oligosaccharides. The first step is the initiation
of the heparosan chain (GlcUA-GlcNAc-UDP) by immobilized
PmHS2-GlcUA+ (column A) in the presence of UDP-GlcUA and
UDP-GlcNAc, which was identified as the acceptor molecule
(Chavaroche et al. 2011). Prior to be incubated with immobilized
PmHS2-GlcNAc+ (column B), the reaction mixture was heat treated
(65 °C/15 min) to prevent residual enzyme activity. Successive incu-
bation cycles of the reaction mixture (UDP-sugars and oligosaccharide
acceptors [heparosan]-GlcNAc-UDP) enable to synthesize heparosan
oligosaccharides of a defined chain length. The oligosaccharides still
remain the UDP-group belonging to the first UDP-GlcNAc acceptor
molecule as determined by MALDI-TOF MS analysis
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sugars and heparosan oligosaccharides) was analyzed by
high-performance anion exchange chromatography
(HPAEC) using an ICS-3000 Ion Chromatography HPLC
system equipped with a CarboPac PA-1 column (2×
250 mm), in combination with a CarboPac PA guard column
(2×25 mm), a VWD-3100 single wave detector (Dionex,
Sunnyvale, USA), and a pulsed electrochemical detector in
pulsed amperometric detection mode (Dionex, Sunnyvale,
CA, USA) in series. The same elution conditions as previ-
ously described were used (Chavaroche et al. 2011). The
presence of a peak with UV detection, as with electrochem-
ical detection, shows the presence of an UDP group
(Orellana and Mohnen 1999).
Matrix-assisted laser desorption–ionization time-of-flight
mass spectrometry analysis An Ultraflex workstation
(Bruker Daltonics, Germany) equipped with a 337-nm laser
was operated in the negative mode and calibrated with a
mixture of peptide standards from Bruker Daltonics. Ions
were accelerated with a 20-kV voltage after a delayed
extraction of 180 ns. Detection was performed using the
reflector mode. Samples were ten times diluted in the matrix
solution containing 10 mg/mL 2,5-dihydroxybenzoic acid in
50% (v/v) acetonitrile. For analysis, 2 μl of the mixture was
transferred to a matrix-assisted laser desorption–ionization
(MALDI) sample plate and dried under a stream of warm
air.
Results
The PmHS2 single-action transferases (PmHS2-GlcUA+ and
PmHS2-GlcNAc+) were immobilized on Ni-NTA agarose
during the purification procedure. The effect of the immobili-
zation on the polymerization activity and stability was deter-
mined first. The parameters influencing the PmHS2
polymerization process and the heparosan chain elongation
were studied next. Therefore, the polymerization activity was
monitored in the presence of non-equal amounts of immobi-
lized PmHS2-GlcUA+ and PmHS2-GlcNAc+, incubated
together in the presence of variable UDP-sugar concentra-
tions. A fractional factorial design was included to determine
the influence of PmHS2-GlcUA+, PmHS2-GlcNAc+, UDP-
GlcUA, and UDP-GlcNAc concentrations. Furthermore, we
used PmHS2-GlcUA+ and PmHS2-GlcNAc+ for step-by-step
elongation of heparosan oligosaccharides in the absence of
oligosaccharide templates.
Enzyme immobilization
By comparing the amount of PmHS2-GlcUA+/PmHS2-
GlcNAc+ protein immobilized onto Ni-NTA agarose and
recovered after the PD10-purification step, it was found that
per volume of induced E. coli culture, the amount of immo-
bilized enzyme and PD10-purified enzymes were compara-
ble based on the protein assay. It was determined that about
0.36 mg of PmHS2 transferases was immobilized per 1 mL
of Ni-NTA slurry (50:50% agarose/buffer). The SDS–PAGE
gel analysis of the fractions washed from the column after
storage at 4°C revealed the presence of a small quantity of
protein, suggesting protein leaching. Thus, in order to avoid
possible contamination of each column by undesired
PmHS2 enzyme activities, the reaction mixtures released
from the columns were heat-inactivated for 15 min at 65 °C
before being applied from column A to column B and vice
versa (Fig. 1).
The combined immobilized PmHS2 single-action trans-
ferases were more stable during storage at 4 °C than the
combined PD10-purified single-action transferases (Fig. 2).
The activity of the immobilized PmHS2 single-action trans-
ferases was stable during 2 days of storage. After 2 weeks of
storage at 4 °C, the immobilized PmHS2 single-action trans-
ferases exhibited about 75%, and after 50 days of storage,
they still exhibited about 60% of their initial activity. The
PD10-purified single-action transferases were not stable at
4 °C; after 1 day of storage, the activity decreased to about
50%, and after 1 week, only 10% of the activity remained.
The addition of ethylene glycol and metal ions (MgCl2 and
MnCl2) in the buffer (Tris–HCl 50 mM, pH 7.15) did not
improve the enzyme stability of the PD10-purified single-
action transferases. Furthermore, immobilization did not
hamper the polymerization process catalyzed by the PmHS2
single-action transferases. Indeed, the specific activity of the
PmHS2 single-action transferase was comparable whether
the enzymes were immobilized or PD10-purified. The
polymerization activity of the PD10-purified PmHS2-
Fig. 2 Storage stability of immobilized and PD10-purified PmHS2
single-action transferases. The PmHS2 single-action transferases
(25–30 μg/mL of each transferase) were incubated together for 24 h
in the presence of 5 mM of each UDP-sugar (closed square immobi-
lized and open square PD10-purified PmHS2 single-action trans-
ferases). The amount of UDP-sugar converted after 24 h of
incubation at 32 °C was quantified by the coupled enzyme assay.
The polymerization activity of the fresh immobilized and PD10-
purified enzymes (t00) was set as 100%
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GlcUA+ and PmHS2-GlcNAc+, incubated together at 32 °C
for 2 to 8 h in the presence of 5 mM UDP-sugars, was about
0.065 nmol/min/μg protein, similar as previously reported
(Chavaroche et al. 2011). Under the same incubation condi-
tion, immobilized PmHS2 single-action transferases added
together exhibited comparable catalytic efficiency, about
0.070 nmol/min/μg protein.
Influence of each transferase domain on the polymerization
activity
We previously reported that the heparosan chain elongation
by PmHS2 is influenced by the UDP-sugar concentrations
(Chavaroche et al. 2010, 2011). Here, in order to determine
the influence of the PmHS2 transferases (glucuronyl trans-
ferase and N-acetylglucosamine transferase) on the heparo-
san initiation and elongation, the polymerization process of
non-equal amount of immobilized PmHS2 single-action
transferases (3 to 48 μg/mL of each transferase) was inves-
tigated when incubated with 1 or 5 mM of each UDP-sugar.
The polymerization activity observed in the presence of
12 μg/mL of each PmHS2 transferase (PmHS2-GlcUA+
and PmHS2-GlcNAc+) was used as a reference (Figs. 3
and 4).
When incubated in the presence of PmHS2 single-action
transferase ratio below 1 (3 to 6 μg/mL E1 and 12 μg/mL
E2), the polymerization process was hampered resulting in a
low polymerization activity (Fig. 3). In the presence of low
concentrations PmHS2-GlcUA+ or PmHS2-GlcNAc+, it is
likely that both the initiation and the chain elongation of
heparosan polymers are hindered, resulting in the synthesis
of heparosan chain concentrations below the detection limit
of the agarose gels (Fig. 4).
When the reaction mixtures were incubated in the pres-
ence of PmHS2 single-action transferase ratio above 1
(E1/E2 >1), the polymerization process was not hampered,
but the ratio of transferases had different effects on the
overall polymerization process. In the presence of an excess
of PmHS2-GlcUA+ (from 12 up to 48 μg/mL) and 1 mM of
each UDP-sugar, the polymerization efficiency increased
proportionally to the increase of PmHS2-GlcUA+ concen-
tration (Fig. 3a). Indeed, in the presence of 36 μg/mL
PmHS2-GlcUA+ and 12 μg/mL PmHS2-GlcNAc+, the
polymerization efficiency increased 2.5 times in comparison
to the efficiency obtained in the presence of equal amounts
of PmHS2-GlcUA+ and PmHS2-GlcNAc+. The polymeri-
zation efficiency also increased proportionally to the
increase of PmHS2-GlcUA+ concentration in the presence
of 5 mM of each UDP-sugar (Fig. 3b). However, it was
observed that for high PmHS2-GlcUA+ concentrations (36
to 48 μg/mL) and a PmHS2-GlcNAc+ concentration of
12 μg/mL, the polymerization efficiency leveled off.
Agarose gel electrophoresis analysis of the reaction mix-
tures (PmHS2-GlcUA+/PmHS2-GlcNAc+) in the presence
of either 1 or 5 mM of each UDP-sugar showed that
increasing amounts of PmHS2-GlcUA+ (below 36 μg/mL)
resulted in the synthesis of heparosan chains with similar
molecular weight and the same size distribution (Fig. 4a).
However, in the presence of 5 mM of each UDP-sugar in the
reaction mixture, compared to 1 mM of UDP-sugars, a
higher number of heparosan chains were synthesized as
shown with the coupled enzyme assay. This suggests that
despite the higher number of chains to elongate the incor-
poration of GlcNAc and GlcUA, residues occurred at the
same velocity for each heparosan chain. Nevertheless, hep-
arosan polymers with a lower molecular weight were syn-
thesized in the presence of 5 mM UDP-sugars and 4-fold
more the amount of PmHS2-GlcUA+ (48 μg/mL) than
PmHS2-GlcNAc+ (12 μg/mL). Probably, the elevated
number of heparosan chains initiated by PmHS2-GlcUA+
either inhibited or saturated PmHS2-GlcNAc+, resulting in
Fig. 3 Influence of each PmHS2 single-action transferase on the
overall polymerization activity. Non-equal amount of freshly immobi-
lized PmHS2-GlcUA+ and PmHS2-GlcNAc+ (ranging from 3 to 48
μg/mL) were mixed together and were incubated for 4 h in the
presence of 1 mM (a) and 5 mM (b) of each UDP-sugar (UDP-GlcUA
and UDP-GlcNAc). The amount of UDP-sugars converted after 4 h of
incubation was determined by the coupled enzyme assay. The poly-
merization activity observed in the presence of equal amount of
PmHS2-GlcUA+ and PmHS2-GlcNAc+ (12 μg/mL of each transferase,
E1/E201) was set at 100% relative activity. In all the experiments, E2
was set as a constant (12 μg/mL) and E1 varied from 3 to 48 μg/mL.
These results have been obtained from triplicate experiments; the
standard deviation was ±3–10%
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the incapability of the PmHS2-GlcNAc+ to elongate all the
chains at the same velocity.
When PmHS2-GlcNAc+ was added in excess to the
incubation mixtures (from 12 to 48 μg/mL), the poly-
merization efficiency did not increase (Fig. 3). The
same observation was made in reaction mixtures incu-
bated with 1 or 5 mM of each UDP-sugar. Agarose gel
electrophoresis analysis and the coupled enzyme assay
confirmed that independently of the PmHS2-GlcNAc+
concentrations (from 12 to 48 μg/mL), the same number
of heparosan chains were initiated and elongated to the
same length (Fig. 4b). These results suggest that the
PmHS2-GlcUA+ activity is limiting the overall polymer-
ization efficiency.
Experimental design analysis
To be able to understand and to control heparosan polymer
elongation using PmHS2 glycosyltransferases, the effect of
combined parameters on PmHS2 polymerization process
were investigated using a fractional factorial design with
four variables (three levels (34 − 1) for each variable). Thus,
27 reaction mixtures were prepared in which different com-
binations of UDP-sugar, and PmHS2 single-action transfer-
ase concentrations were added (Supplementary information
Table 1). The reaction mixtures were analyzed by the cou-
pled enzyme assay to monitor the polymerization efficiency
(data not shown), and they were also analyzed by HPSEC to
assess the polymer elongation process.
Using the Mallow’s Cp criterion, the analysis of the 27
reaction mixtures showed that eight parameters (R2 0.848)
were needed to obtain the best fitting model. The following
equation describes the influence of the single-action trans-
ferase concentrations and UDP-sugar concentrations on the
heparosan elongation process:
heparosan molecular mass ¼ 24:82þ 2:24 PmHS2 GlcNAcþ½ þ1:07 PmHS2  GlcUAþ½ þ2:34 UDP GlcNAc½ 0:03 PmHS2 GlcNAcþ½ 2
1:77E 02 PmHS2 GlcUAþ½ 28:57 PmHS2  GlcNAcþ½  UDP GlcUA½ 0:16 PmHS2 GlcNAcþ½  UDP GlcNAc½ 
þ0:57 UDP GlcUA½  UDP GlcNAc½ :
This model showed that the four variables (PmHS2-
GlcUA+, PmHS2-GlcNAc+, UDP-GlcUA, and UDP-
GlcNAc concentrations) influenced the polymerization
activity with respect to the heparosan molecular weight.
It was found that only the PmHS2-GlcNAc+ (x1),
PmHS2-GlcUA+ (x2), and UDP-GlcNAc (x4) concentra-
tions are represented as main effect. In addition, the
coefficient for the PmHS2-GlcNAc+ concentration is
higher than for the PmHS2-GlcUA+ concentration. De-
spite the fact that the UDP-GlcUA concentration (x3) was
not represented as a main effect, the interaction effects
showed that UDP-GlcUA concentration influences the
heparosan elongation. The analysis of the contour plot
visualization obtained from this analysis is presented in
Fig. 5.
In reaction mixtures incubated with increasing concen-
trations of PmHS2-GlcUA+ (7, 21, or 34 μg/mL) and a
constant concentration of PmHS2-GlcNAc+ (Fig. 5, from
left to right), it was observed that the polymer molecular
weight was neither influenced by the UDP-sugar concentra-
tion nor by the PmHS2-GlcUA+ concentrations (Fig. 5a–c).
Nevertheless, the increase of PmHS2-GlcUA+ concentration
resulted in the synthesis of a higher number of heparosan
chains and higher polymerization efficiency, as observed
Fig. 4 Agarose gel of
heparosan polymers
synthesized in the presence of
non-equal amount of immobi-
lized PmHS2 single-action
transferases. The reaction mix-
tures were incubated for 4 h in





(E1/E2 ratio ranging from 0.25
to 4, in which E103 to 48 μg/
mL and E2012 μg/mL,
respectively)
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using the coupled enzyme assay (data not shown). In the
presence of a low PmHS2-GlcUA+ concentration (7 μg/mL),
the polymerization was hampered as it can be assessed by the
blue color trend (Fig. 5a); this is probably due to the low
number of heparosan chain initiated.
In the reaction mixtures incubated in the presence of in-
creasing PmHS2-GlcNAc+ concentrations (7, 21, or 34 μg/
mL) in combination with a constant concentrations of
PmHS2-GlcUA+ (Fig. 5, from top to bottom) resulted in
different polymer elongation profiles as function of the
UDP-sugar concentration present in the reaction mixture
(Fig. 5d–f). A constant concentration of PmHS2-GlcUA+ in
the reaction mixture implies the initiation of the same number
of heparosan chains at a given UDP-sugar concentration.
Thus, the polymerization trend observed is mainly the result
of the PmHS2-GlcNAc+ concentration. In the presence of a
low concentration of PmHS2-GlcNAc+ (7 μg/mL), the lon-
gest heparosan polymers were synthesized when incubated
with high UDP-sugar concentrations (Fig. 5d). The fact that
the polymerization occurred in the presence of a high UDP-
sugar concentration suggests that PmHS2-GlcNAc+ required
a high concentration of heparosan oligosaccharides to perform
its catalytic activity. Therefore, it was assumed that the
affinity of the GlcNAc acceptor site is low. For the
intermediate concentration of PmHS2-GlcNAc+ (21 μg/
mL), it seemed that the synthesis of long heparosan
polymers was favored in the presence of either high or
low equimolar UDP-sugar concentrations (Fig. 5e),
while the production of long heparosan chains and the
polymerization activity was hampered in the presence of
low UDP-GlcNAc concentrations combined with high
UDP-GlcUA concentrations, incubation conditions
which were determined to be not suitable to initiate
heparosan chains (Chavaroche et al. 2011). In the pres-
ence of high PmHS2-GlcNAc+ (34 μg/mL) concentra-
tions, the longest polymers were obtained when
incubated in the presence of low UDP-sugar concentra-
tion (Fig. 5f). Low UDP-sugar concentrations resulted in
Fig. 5 Contour plot visualization of the statistical analysis of the
PmHS2 single-action transferase polymerization activity with respect
to the polymer molecular weight. The reaction mixtures were prepared
according to a fractional factorial design with four variables and three
levels (34 − 1) for each variable (immobilized PmHS2-GlcUA+ and
immobilized PmHS2-GlcNAc+ (micrograms per milliliter), UDP-
GlcUA, and UDP-GlcNAc (millimolars)). After 4 h of incubation at
32 °C, the heparosan average molecular mass (kilodaltons, presented in
the scale at the right of each graph) was determined by high-
performance size exclusion chromatography. The data were visualized
using the mathematical software package Matlab
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the synthesis of a lower number of heparosan chains
(Chavaroche et al. 2010), which may avoid the satura-
tion of the PmHS2-GlcNAc+ acceptor site and thus
favor the elongation process.
Step-by-step elongation of heparosan oligosaccharides
It was observed that PmHS2 polymerization process is
influenced by both transferase activities and both UDP-
sugar concentrations, rendering the control of heparosan
chain elongation difficult. PmHS2-GlcUA+ was reported to
initiate heparosan chains when incubated in the presence of
both UDP-sugars (Chavaroche et al. 2011). This implies that
PmHS2-GlcUA+ is active without forming a protein com-
plex with PmHS2-GlcNAc+. To determine if PmHS2-
GlcNAc+ is also active as a single function transferase and
thus to evaluate if the PmHS2-single-action transferases
could be used to elongate step-by-step heparosan oligosac-
charides in the absence of template molecules, PmHS2-
GlcUA+ and PmHS2-GlcNAc+ were immobilized on
Ni-NTA resin and loaded in separate columns. In order to
control the elongation of heparosan oligosaccharides, the
reaction mixtures (buffer, UDP-sugars, and oligosacchar-
ides) were recycled from one column (A) to the other (B)
(Fig. 1). The analysis of the reaction mixture using HPAEC,
MALDI–time-of-flight mass spectrometry (TOF MS), and
20% TBE gel electrophoresis (data not shown) showed that
heparosan oligosaccharides with a defined length could be
synthesized by the PmHS2 single-action transferases in the
absence of oligosaccharide templates. The monitoring of the
reaction mixtures after each incubation step by HPAEC and
MALDI-TOF MS showed that the oligosaccharides were
completely converted after each incubation steps (Figs. 6
and 7). As can be observed with HPAEC (Fig. 6), the
disaccharides (DP2) synthesized during the “step 1” incu-
bation, in the presence of PmHS2-GlcUA+ (column A),
were totally converted into trisaccharides (DP3) at the end
of the “step 2” incubation in the presence of PmHS2-
GlcNAc+ (column B). Analysis of the “step 2” reaction
mixture by MALDI-TOF MS showed the absence of dis-
accharides and confirmed the total conversion of the DP2
into DP3 by PmHS2-GlcNAc+. At the end of the “step 3”
incubation with PmHS2-GlcUA+ only, disaccharides (DP2)
and tetrasaccharides (DP4) heparosan were observed by
both HPAEC and MALDI-TOF MS analysis.
Analysis of the oligosaccharide content (HPAEC and
MALDI-TOF MS) of the different reaction mixtures (step
3 to step 9) showed that the incubation in the presence of
PmHS2-GlcNAc+ resulted only in odd numbered oligosac-
charides (DP3, DP5, and DP7), while even numbered oli-
gosaccharides (DP2, DP4, DP6, and DP8) were found only
after incubation with PmHS2-GlcUA+ (Fig. 7). The pres-
ence of only odd numbered oligosaccharides in the PmHS2-
GlcNAc+ mixtures is due to the fact that PmHS2-GlcNAc+
is not capable of initiating the elongation of heparosan and
thus cannot synthesize even numbered oligosaccharides.
The presence of heparosan oligosaccharides with different
elongation degree showed that the initiation of new chains
occurred during each incubation step with PmHS2-GlcUA+.
Fig. 6 High-performance anion exchange chromatography analysis of
the reaction mixtures obtained after different incubation steps in the
presence of immobilized PmHS2-GlcUA+ or PmHS2-GlcNAc+. Hep-
arosan disaccharides (DP2) were released from the PmHS2-GlcUA+
column (column A; 0.5 mg PmHS2-GlcUA+/mL reaction, incubation
step 1), heparosan trisaccharide (DP3) from the PmHS2-GlcNAc+
column (column B; 0.5 mg PmHS2-GlcNAc+/mL reaction, incubation
step 2), and a mixture of heparosan disaccharides (DP2) and tetrasac-
charides (DP4) from the PmHS2-GlcUA+ column (incubation step 3).
UMP, UDP-GlcNAc, UDP, and UDP-GlcUA (not shown) eluted after
21.1, 23.5, 26.0, and 33.6 min, respectively. The annotation DPX stands
for “degree of polymerization X,” in which X represents the number of
monosaccharide units
Fig. 7 High-performance anion exchange chromatography analysis of
the reaction mixture released from the PmHS2-GlcUA+ column
(column A). Even numbered heparosan oligosaccharide mixture from
disaccharides up to octasaccharides was synthesized by the immobi-
lized PmHS2 single-action transferases (0.5 mg/mL PmHS2-GlcUA+
and 0.5 mg/mL PmHS2-GlcNAc+), as shown in Fig. 1. The reaction
mixture was obtained after nine successive incubation cycles (last
incubation cycle on column A). The annotation DPX stands for “degree
of polymerization X”, in which X represents the number of monosac-
charide units
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Residual amount of UDP-GlcNAc in the reaction mixture is
probably responsible for the initiation of new chains. After
nine successive incubation cycles in PmHS2-GlcUA+ and
PmHS2-GlcNAc+ columns, the reaction mixture released
from PmHS2-GlcUA+ column showed that only even num-
bered heparosan oligosaccharides (disaccharides (DP2) to
octasaccharides (DP8)) were produced (Fig. 7). The disac-
charides GlcUA-GlcNAc-UDP (DP2) eluted after 28.8 min,
and the other heparosan oligosaccharides of DP4, DP6, and
DP8 eluted after 29.4, 30.0, and 30.6 min, respectively. The
analysis of the reaction mixtures by MALDI-TOF MS
showed that the UDP group still remained attached to the
growing oligosaccharide chains (DP2 m/z 782.6, DP4 m/z
1,160.3, DP6 m/z 1,539.0, and DP8 m/z 1,918.0).
Discussion
In this report, we showed that PmHS2-GlcUA+/PmHS2-
GlcNAc+ were successfully immobilized on Ni-NTA aga-
rose during the purification step. The polymerization activ-
ity of freshly PD10-purified and freshly immobilized
PmHS2 single-action transferases was found to be similar,
and it was shown that immobilization did not have any
effect on the polymerization activity. The stability of the
combined single-action transferases increased when stored
at 4 °C. The single-action transferases have not been studied
separately, and the decrease of the stability could be due to
only one of the two single-action transferases.
Previously it has been shown that the single-action trans-
ferases can be used as a model to describe dual transferase
PmHS2 activity (Chavaroche et al. 2011); thus, immobilized
PmHS2 single-action transferases can also be used to study
PmHS2 polymerization mechanism. The use of IMAC such
as Ni-NTA agarose is frequently reported for the purification
of protein, but its usage for immobilization purpose is not
common (Liu et al. 2002). Here we showed that it is a
suitable method to study PmHS2 transferases.
Influence of each transferase domains on the polymeri-
zation activity. The PmHS2 polymerization process was
investigated in the presence of different ratios of PmHS2-
GlcUA+ and PmHS2-GlcNAc+. It was found that both
transferase domains do not exhibit the same catalytic
efficiency.
Here, we report that the addition of an excess of PmHS2-
GlcUA+ in comparison to PmHS2-GlcNAc+ increased the
polymerization activity, while an excess of PmHS2-
GlcNAc+ did not influence the catalytic efficiency. The
results suggest that the glucuronyl transferase (PmHS2-
GlcUA+) is the limiting catalyst in the overall PmHS2
polymerization process, either by controlling the amount
of chain initiated and by exhibiting per heparosan chain a
slow and a constant rate in transferring GlcUA residue in
comparison to the GlcNAc transfer by PmHS2-GlcNAc+.
We previously reported that for a same amount of protein,
the specific activity of PmHS2-single-action transferases
was 2-fold lower than for PmHS2 (Chavaroche et al.
2011). The results obtained now certainly indicate that
PmHS2 single-action transferases exhibit similar polymeri-
zation efficiency as PmHS2. Indeed, the difference of activ-
ity previously observed might have been due to the fact that
with comparable amounts of PmHS2-single-action trans-
ferases and PmHS2, there is twice less active PmHS2-
GlcUA+ in the reaction mixture of PmHS2-single-action
transferases compared to the one with PmHS2. It was also
observed that N-acetylglucosaminyl transferase (PmHS2-
GlcNAc+) is either saturated or inhibited in the presence of
a too high number of chains. This may explain why PmHS2
synthesizes low molecular weight heparosan polymers in
the presence of high UDP-sugars concentrations
(Chavaroche et al. 2010).
In addition, the analysis of the experimental design
showed that the four variables: PmHS2-GlcUA+, PmHS2-
GlcNAc+, UDP-GlcUA, and UDP-GlcNAc concentrations
influence the heparosan elongation. This is in agreement
with what has been reported previously for the PmHS2
polymerization process (Chavaroche et al. 2010, 2011). It
was observed that the polymer chain length and size distri-
bution is mainly determined by the number of chain initiated
which depends on the concentration of UDP-sugars
(Chavaroche et al. 2010), on the number of acceptor mole-
cules (UDP-GlcNAc) (Chavaroche et al. 2011), and on the
number of acceptor sites (PmHS2-GlcUA+). The heparosan
chain length is also influenced by the catalytic efficiency of
the transferases to elongate heparosan chains. The PmHS2-
GlcNAc+ was found to play a critical role in the heparosan
chain length, by being saturated or inhibited in the presence
of a too high number of chains. These results correlate with
previously observed results when the dual action transferase
PmHS2 was incubated with high concentration of UDP-
sugars (Chavaroche et al. 2010).
Also, for the first time, we showed that PmHS2 single-
action transferases are independent and do not need com-
plex formation with each other to exhibit activity. This
represents a great advantage over the mammalians heparo-
san synthases (EXT1 and EXT2) (Mccormick et al. 2000;
Kim et al. 2003) and the E. coli heparosan synthases (KfiC
and KfiA) (Griffiths et al. 1998; Hodson et al. 2000; Sugiura
et al. 2010) to control the elongation of heparosan.
For the first time, PmHS2 single-action transferases have
been used to elongate step-by-step heparosan oligosacchar-
ides. It was observed for each incubation step that the
heparosan oligosaccharides were completely elongated.
Since only PmHS2-GlcUA+ is capable to initiate heparosan
chains (Chavaroche et al. 2011), this resulted in the presence
of only even numbered heparosan oligosaccharides when
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incubated with PmHS2-GlcUA+ and only odd numbered
oligosaccharides with PmHS2-GlcNAc+. HPAEC analysis
revealed that the odd numbered oligosaccharides (non-
reducing end GlcNAc) eluted earlier than the even num-
bered oligosaccharides (non-reducing end GlcUA). The
trisaccharide GlcNAc-GlcUA-GlcNAc-UDP eluted at
25.8 min, while the disaccharide GlcUA-GlcNAc-UDP eluted
at 28.8 min. This kind of elution behavior has been reported
before for hyaluronan oligosaccharides (Price et al. 1997;
Blundell and Almond 2006). The analysis of the reaction
mixtures by MALDI-TOF MS showed that the UDP group
remained attached to the growing oligosaccharide chains. The
effect of the UDP-group during medical application should be
evaluated, and if needed, an additional step leading to the
UDP removal should be implemented.
The controlled synthesis of GAGs has not been reported
yet in the absence of template (Deangelis et al. 2003;
Sugiura et al. 2008; Liu et al. 2010). This approach is of
interest since the production of template molecules is ex-
pensive and laborious. Production of templates either by
chemical hydrolysis (Sismey-Ragatz et al. 2007) or enzy-
matic degradation (Ernst et al. 1995) of heparosan K5 poly-
saccharides is not a well-controlled process, and thus to
obtain monodisperse heparosan molecules, a fractionation
step is required. In addition, heparin lyases cleave the gly-
cosidic bond via an elimination reaction resulting in the
formation of oligosaccharides containing unsaturated uronic
acid residues at the non-reducing end terminus. In order to
use the templates for polymerization, the saturated uronic
acid residues need to be removed using mercuric salts or by
ozonolysis (Ludwigs et al. 1987; Masuko et al. 2011).
Synthesis of heparosan disaccharides from nucleotide sug-
ars requires the incubation of PmHS2-GlcUA+ in the pres-
ence of both UDP-sugars (Chavaroche et al. 2011). The
production of a mixture of heparosan oligosaccharides is
due to the initiation of new heparosan chains for each
elongation step with PmHS2-GlcUA+. This shows that both
UDP-GlcNAc and UDP-GlcUA are present in the reaction
mixture. Thus, to synthesize monodisperse heparosan oligo-
saccharides, the incubation conditions enabling to reach the
complete conversion of the UDP-GlcNAc by PmHS2-
GlcNAc+ should be determined to avoid the presence of
both UDP-sugars when incubated with PmHS2-GlcUA+.
Furthermore, at the end of the second incubation step, the
purification of the heparosan trisaccharides to be used as
templates could facilitate the production of monodisperse
heparosan polymers during the step-by-step elongation.
This research describes for the first time the ability to
elongate heparosan oligosaccharides step by step using
single-action heparosan transferases from P. multocida.
Due to the uncontrolled hydrolysis of UDP-sugar, a precise
quantitation was not possible. The reactions should be opti-
mized (at this moment on microgram scale) in order to
increase the yield of oligosaccharide synthesized per amount
of substrate. By improving all the aspects mentioned above,
higher yields of enzymatically synthesized well-defined
heparosan chain length should be possible.
To summarize, we found that both UDP-sugars and both
heparosan transferases influence the polymerization with
respect to the catalytic efficiency and the polymer molecular
weight. The glucuronyl transferase (PmHS2-GlcUA+) cata-
lytic activity is limiting the overall polymerization process
activity, and the N-acetylglucosaminyl transferase (PmHS2-
GlcNAc+) influences the polymer elongation depending on
the number of chains to elongate and the UDP-sugar con-
centrations present in the reaction mixture. A more detailed
analysis of the kinetic parameters should help to further
optimize the polymerization conditions to control heparosan
chain length and size distribution. We also showed, for the
first time, that PmHS2 single-action transferases incubated
separately in the absence of template molecules are capable
to elongate step-by-step heparosan oligomers. PmHS2-
GlcUA+ and PmHS2-GlcNAc+ are not only independent
transferases, but they can also use modified UDP-sugars to
elongate heparosan (Sismey-Ragatz et al. 2007; Liu et al.
2010). These properties are of interest to facilitate the in
vitro synthesis of Hep/HS-like products (Liu et al. 2010) and
to enlarge the potential of heparin and heparan sulfate bio-
logical activity (Sismey-Ragatz et al. 2007). In the future,
more research is needed to produce heparosan oligosacchar-
ides with a defined chain length and in high quantity in
order to determine their exact biological properties in in
vitro and in vivo experiments.
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